Insulet to Present at Upcoming Investor Conferences
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology, will present at three virtual investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences:
- The Canaccord Genuity 2020 MedTech & Diagnostics Forum on Thursday, November 19, 2020, at 12:30 p.m. (Eastern Time)
- The Piper Sandler 32nd Annual Healthcare Conference – the presentation will be available for viewing on Monday, November 23, 2020
- The Nasdaq 43rd Investor Conference on Wednesday, December 2, 2020, at 11:30 a.m. (Eastern Time)
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com. Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.omnipod.com.
Contacts
Investor Relations:
Deborah R. Gordon
Vice President, Investor Relations
(978) 600-7717
dgordon@insulet.com
Jason McGorman
Principal Investor Relations Analyst
(978) 600-7972
jmcgorman@insulet.com
Media:
Angela Geryak Wiczek
Senior Director, Corporate Communications
(978) 932-0611
awiczek@insulet.com